INFORACIÓN ACADÉMICA Y ADMISIONES

Credits - 70 / European ECTS credits

Pre-selection process: Open

Inscriptions: from January 2019 to September 2019

Master Program – 14th October 2019 to 19th June 2020.

Full Time - Monday to Thursday from 18:00h. to 21:00h.

Language - English

Limited Places

OBJETIVOS DEL MÁSTER

The objective of the programme is to acquire the knowledge to develop biotech companies in drug discovery, knowledge transfer and capital increases to develop in early stage preclinical and clinical phases. The main skills and topics are related with financial statements, entrepreneurships, valuation models, venture funds, financing rounds and international relationships within the different stake holders in life sciences.

DESARROLLO PROFESIONAL 

The students of our master programs will have the opportunity to work in teams of some of the most important global pharmaceutical companies as well as new biotechnology companies, developing innovative products inside the biomedical sector. Their demanded profiles allow the students to work in different roles and departments in biotech companies, consultancies, pharmaceutical companies, technology transfer offices from hospitals and research centers. 

PROGRAMA ACADÉMICO

I. Global Ecosystem in Drug Discovery

II. Scientific and Regulatory Developemt

III. Profesional and Personal Leadership

IV. Biotechnology Based Companies

V. Venture Capital and Funding

VI. Master's Thesis - Drug Discovery Business Plan

See the full Academic Programme

TITULACIÓN DEL MASTER

Los estudiantes que aprueben el programa recibirán una doble titulación de la Universidad de Barcelona y el Instituto Empresarial de Biotecnologia en Master in Business Administration in LifeScience con especialidad en International Business Administration.

                    


 

Solicitud de información